LIGAND MOTIFS OF HLA-DRB5-ASTERISK-0101 AND DRB1-ASTERISK-1501 MOLECULES DELINEATED FROM SELF-PEPTIDES

被引:0
作者
VOGT, AB
KROPSHOFER, H
KALBACHER, H
KALBUS, M
RAMMENSEE, HG
COLIGAN, JE
MARTIN, R
机构
[1] UNIV TUBINGEN,SCH MED,DEPT NEUROL,D-72076 TUBINGEN,GERMANY
[2] UNIV TUBINGEN,CTR MED & NAT SCI,TUBINGEN,GERMANY
[3] GERMAN CANC RES CTR,TUMOR IMMUNOL PROGRAM,W-6900 HEIDELBERG,GERMANY
[4] GERMAN CANC RES CTR,DEPT TUMORVIRUS IMMUNOL,W-6900 HEIDELBERG,GERMANY
[5] NIAID,BIOL RESOURCES BRANCH,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigenic peptides are presented to CD4(+) T cells by MHC class II molecules via a highly polymorphic peptide-binding groove. The two HLA-DR alleles isotypically expressed on HLA-DR15Dw2-positive cells, DRB1*1501 (DR2b) and DRB5*0101 (DR2a) molecules, show a number of differences in polymorphic residues of the beta-chain, including the Gly-Val-dimorphism at position beta 86. Therefore, different requirements for interaction of peptides with these alleles must be expected. In this study, naturally processed self-peptides were eluted from purified HLA-DR15Dw2 molecules and related to DRB1*1501 or DRB5*0101 molecules by binding assays. An alignment of self-peptides and foreign peptides allowed the delineation of putative anchor motifs. N- and C-terminally truncated and alanine-substituted derivatives of the DR15Dw2 restricted myelin basic protein epitope MBP(85-105) confirmed their validity. Thus, DRB5*0101 requires a bulky hydrophobic residue (F or Y) at position i as a primary anchor, and Q or an aliphatic residue, such as V, I, or M, at position 1 + 3; positively charged residues at positions 1 + 7 and 1 + 8 are secondary anchors. For DRB1*1501, a nonaromatic, hydrophobic anchor (L, V, or I) at position i is supplemented by a bulky hydrophobic residue (F or Y) at position i + 3 as primary anchor; an additional hydrophobic side chain respresented by M, I, V, or F occurs at position i + 6. Therefore, MBP(85-105) seems to contain two MHC interaction sites for DRB1*1501 and DRB5*0101, respectively, that may contribute to its immunodominance. Because HLA-DR15 Dw2 is associated with susceptibility to develop multiple sclerosis, the delineation of ligand motifs of the two DR2 alleles may help to study the interaction between potential autoantigenic peptides and these molecules in the future.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 33 条
[21]   TOLERANCE TO A SELF-PEPTIDE FROM THE 3RD HYPERVARIABLE REGION OF HLA-DRB1-ASTERISK-0401 IN NORMALS AND PATIENTS WITH RA [J].
SALVAT, S ;
ROCHELLE, L ;
ROUDIER, J .
ARTHRITIS AND RHEUMATISM, 1993, 36 (09) :S88-S88
[22]   Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1 [J].
Löffler, D ;
Welschof, M ;
Goldmann, SF ;
Wölpl, A .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1998, 25 (05) :339-347
[23]   TCR V-BETA SELECTION FROM A DRB1-ASTERISK-401-ASTERISK-0101 PATIENT WITH RHEUMATOID-ARTHRITIS COMPLICATED BY A CD8+ T-CELL INFILTRATED RHEUMATOID PERICARDITIS [J].
TRAVAGLIOENCINOZA, A ;
ANAYA, JM ;
DANGEAC, AD ;
SANY, J ;
REME, T .
JOURNAL OF RHEUMATOLOGY, 1994, 21 (07) :1373-1375
[24]   Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein [J].
Smith, KJ ;
Pyrdol, J ;
Gauthier, L ;
Wiley, DC ;
Wucherpfennig, KW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1511-1520
[25]   HLA-DRB1 molecules and the presentation of anchor peptides from RhD, RhCE, and KEL proteins [J].
De Souza, Conceicao Pinheiro ;
Baleotti, Wilson ;
Moritz, Elyse ;
Sanches, Sidneia ;
Lopes, Larissa Barbosa ;
Chiba, Akemi Kuroda ;
Donadi, Eduardo Antonio ;
Bordin, Jose Orlando .
TRANSFUSION, 2021, 61 (05) :1617-1630
[26]   ABSENCE OF AN ASSOCIATION BETWEEN HLA-DRB1-ASTERISK-04 AND RHEUMATOID-ARTHRITIS IN NEWLY-DIAGNOSED CASES FROM THE COMMUNITY [J].
THOMSON, W ;
PEPPER, L ;
PAYTON, A ;
CARTHY, D ;
SCOTT, D ;
OLLIER, W ;
SILMAN, A ;
SYMMONS, D .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (07) :539-541
[27]   DRB1-ASTERISK-0301 MOLECULES RECOGNIZE A STRUCTURAL MOTIF DISTINCT FROM THE ONE RECOGNIZED BY MOST DR-BETA(1) ALLELES [J].
SIDNEY, J ;
OSEROFF, C ;
SOUTHWOOD, S ;
WALL, M ;
ISHIOKA, G ;
KONING, F ;
SETTE, A .
JOURNAL OF IMMUNOLOGY, 1992, 149 (08) :2634-2640
[28]   TOLERANCE TO A SELF-PEPTIDE FROM THE 3RD HYPERVARIABLE REGION OF HLA-DRB1-ASTERISK-0401 IN RHEUMATOID-ARTHRITIS PATIENTS AND NORMAL SUBJECTS [J].
SALVAT, S ;
AUGER, I ;
ROCHELLE, L ;
BEGOVICH, A ;
GEBURHER, L ;
SETTE, A ;
ROUDIER, J .
JOURNAL OF IMMUNOLOGY, 1994, 153 (11) :5321-5329
[29]   NATURALLY PROCESSED PEPTIDES DERIVED FROM THE RHEUMATOID ARTHRITIS-ASSOCIATED MHC ALLELE DRB1-ASTERISK-0404 ARE PRESENT AS NESTED CLUSTERS [J].
HAYDEN, JB ;
DAVEY, MP .
ARTHRITIS AND RHEUMATISM, 1993, 36 (09) :S88-S88
[30]   THE NUMBER OF DONOR-HLA-DERIVED PEPTIDES PRESENTED BY RECIPIENT DRB3/4/5 AND DQA1-DQB1 IN KIDNEY-TRANSPLANTED RECIPIENTS ARE INDEPENDENT FROM THE NUMBER OF DRB1-PRESENTED PEPTIDES [J].
Niemann, Matthias ;
Geneugelijk, Kirsten ;
Spierings, Eric ;
Tomosugi, Toshihide ;
Kobayashi, Takaaki .
HLA, 2019, 93 (05) :293-293